| 1 |
28884930 | Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy. | 2018 Mar |
1 |
| 2 |
28261382 | Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C. | 2017 Feb 18 |
1 |
| 3 |
26991414 | Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy. | 2016 Oct |
1 |
| 4 |
26095167 | Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection. | 2015 Dec |
1 |
| 5 |
26668696 | Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching. | 2015 Dec 8 |
2 |
| 6 |
25349647 | Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis. | 2014 Oct 27 |
1 |
| 7 |
28520373 | Simeprevir Therapy and IFNL3 Genotype | 2012 |
3 |